Unlocking the Long-Term Value Proposition: A Comprehensive Analysis of the Cost-Effectiveness of Glatiramer Acetate in the Treatment Landscape of Relapsing-Remitting Multiple Sclerosis from the UK NHS Perspective
dynamic realm of Multiple Sclerosis (MS) treatment, the spotlight has recently been cast on the long-term effects of Glatiramer Acetate (GA) and interferons-ß (IFNs), particularly within the confines ... Multiple…

